Inventor
KURT ZIMMERMANN
Inventor
US
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
C07DHeterocyclic compounds29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
C07CAcyclic or carbocyclic compounds4%
G01NInvestigating or analysing materials by determining their chemical or physical properties4%
G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology4%
G16CComputational chemistry4%
PatentTitleYear
12,569,464Protein-protein interaction inducing technology202612,441,708Cereblon ligands and bifunctional compounds comprising the same202512,264,157Compounds and methods for the enhanced degradation of targeted proteins202511,986,531Compounds and methods for the targeted degradation of rapidly accelerated fibrosarcoma polypeptides202411,964,945Compounds and methods for the targeted degradation of androgen receptor202411,512,083Compounds and methods for the enhanced degradation of targeted proteins202211,427,548Compounds and methods for the targeted degradation of androgen receptor202211,236,051Compounds and methods for the targeted degradation of androgen receptor2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to ARVINAS OPERATIONS INC (8)· patent assignee history
2022–2025Patents assigned to UNIV YALE (3)· patent assignee history
2022–2026Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ARVINAS OPERATIONS INC | 8 | 2022–2026 |
| UNIV YALE | 3 | 2022–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 8 | 2022–2026 |